1-4 of 4
Silvia Locatelli, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Martina Di Trani, Ettore Rizzo, Silvia Locatelli, PhD, Fabrizio Marino, MD, Vanessa Cristaldi, PhD, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Federica De Paoli, PhD, Giuseppa Careddu, Marcello Rodari, MD, Margarita Kirienko, MD, Eleonora Calabretta, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesca Ricci, MD, Arturo Chiti, MD, Armando Santoro, Stefan Hohaus, MD, Davide Rossi, MD PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 131.
https://doi.org/10.1182/blood-2019-131096
Published: 2019
Journal Articles

Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma

Silvia Locatelli, PhD, Arianna Giacomini, PhD, Anna Guidetti, MD, Loredana Cleris, PhD, Michele Magni, MD, Massimo Di Nicola, MD, Roberta Mortarini, PhD, Alessandro M Gianni, MD, Andrea Anichini, PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2011) 118 (21): 1653.
https://doi.org/10.1182/blood.V118.21.1653.1653
Published: 2011
Journal Articles

Phosphorylation Levels of Extracellular-Signal Regulated Kinase (ERK) and AKT in Circulating Lymphocytes Predict Response to Targeted Therapy with Kinase Inhibitors in Refractory/Relapsed Hodgkin Lymphoma Patients,

Anna Guidetti, MD, Silvia Locatelli, PhD, Simonetta Viviani, MD, Anna Dodero, MD, Lucia Farina, MD, PhD, Domenico Russo, Pietro Bulian, Roberto Sorasio, MD, Massimo Di Nicola, MD, Paolo Corradini, MD, Andrea Anichini, PhD, Alessandro M. Gianni, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2011) 118 (21): 3705.
https://doi.org/10.1182/blood.V118.21.3705.3705
Published: 2011
Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Marco Ruella, MD, Rosalba Miceli, MD, Liliana Devizzi, MD, Daniela Sia, PhD, Silvia Locatelli, PhD, Arianna Giacomini, PhD, Michele Magni, MD, Paola Matteucci, MD, Stefano Buttiglieri, PhD, Alessandra Risso, PhD, Luigi Mariani, MD, Roberto Passera, PhD, Massimo Di Nicola, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2010) 116 (21): 1289.
https://doi.org/10.1182/blood.V116.21.1289.1289
Published: 2010